Earnings History Data for Zentalis Pharmaceuticals, Inc. (ZNTL) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering and developing small molecule therapeutics targeting cancers. The company's lead programs consist of ZN-c5, an oral selective estrogen receptor degrader for estrogen-receptor-positive, HER2-negative breast cancer which is in clinical stage. It operates principally in New York and San Diego. Zentalis Pharmaceuticals, Inc. is based in NEW YORK.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 09-08-2024 | PM | ZNTL | Zentalis Pharmaceuticals | 233.00 | -1.24 | -0.83 | 0.00 | Zentalis Pharmaceuticals GAAP EPS of -$1.24 [8/9/2024 10:09 AM] |
3.00 | -0.31 (-9.21%) |
3.09 | -0.22 (-6.65%) |
2.96 - 29.03 | 602,360 | 720,000 | 564 | ||
| 07-05-2024 | PM | ZNTL | Zentalis Pharmaceuticals | 832.00 | 0.14 | -0.85 | 0.00 | Zentalis Pharmaceuticals GAAP EPS of $0.14, revenue of $40.56M [5/7/2024 7:44 AM] |
12.32 | 0.60 (5.12%) |
0.0 | 0.0 (0.00%) |
9.56 - 31.46 | 417,523 | 650,000 | 0 | ||
| 27-02-2024 | PM | ZNTL | Zentalis Pharmaceuticals | 968.00 | -0.83 | -0.92 | 0.00 | Zentalis Pharmaceuticals GAAP EPS of -$4.47 beats by $0.06 [2/27/2024 7:26 AM] |
14.64 | 0.56 (3.98%) |
0.0 | 0.0 (0.00%) |
9.56 - 31.46 | 863,204 | 830,000 | 0 | ||
| 06-11-2023 | PM | ZNTL | Zentalis Pharmaceuticals | 1,174 | -0.79 | -1.01 | 0.00 | Zentalis Pharmaceuticals GAAP EPS of -$0.79 beats by $0.15 [11/6/2023 7:26 AM] |
12.44 | -5.44 (-30.43%) |
18.19 | 0.31 (1.73%) |
12.10 - 31.46 | 4,366,316 | 860,000 | 5,241 | ||
| 10-05-2023 | PM | ZNTL | Zentalis Pharmaceuticals | 1,300 | -1.07 | -0.96 | 0.00 | Zentalis Pharmaceuticals GAAP EPS of -$1.07 [5/10/2023 1:28 PM] |
24.35 | 1.54 (6.75%) |
0.0 | 0.0 (0.00%) |
15.55 - 32.34 | 835,151 | 860,000 | 0 | ||
| 09-08-2022 | AH | After the close (Aug 9) |
ZNTL | Zentalis Pharmaceuticals | 1,432 | -1.34 | -1.21 | 0.00 | Zentalis Pharmaceuticals GAAP EPS of -$1.34 misses by $0.17 [8/9/2022 5:31 PM] |
30.83 | 0.42 (1.38%) |
30.41 | 0.0 (0.00%) |
17.33 - 87.19 | 472,093 | 600,000 | 15,119 | |
| 05-05-2022 | PM | ZNTL | Zentalis Pharmaceuticals | 1,214 | -1.31 | -1.20 | 0.00 | Zentalis Pharmaceuticals GAAP EPS of -$1.31 misses by $0.10 [5/5/2022 8:14 AM] |
24.77 | -1.90 (-7.12%) |
26.67 | 0.0 (0.00%) |
21.18 - 87.19 | 469,014 | 618,296 | 252,899 | ||
| 24-02-2022 | PM | 7:00 AM ET (Feb 24) |
ZNTL | Zentalis Pharmaceuticals | 2,237 | -1.11 | -1.34 | 0.00 | Zentalis Pharmaceuticals GAAP EPS of -$1.11 beats by $0.22 [2/24/2022 7:49 AM] |
50.12 | 2.47 (5.17%) |
0.0 | 0.0 (0.00%) |
34.48 - 87.19 | 62,012 | 304,236 | 0 | |
| 10-11-2021 | PM | ZNTL | Zentalis Pharmaceuticals | 3,519 | -0.09 | -1.31 | 0.00 | Zentalis Pharmaceuticals EPS beats by $1.22 [11/10/2021 8:56 AM] |
78.24 | 0.14 (0.18%) |
0.0 | 0.0 (0.00%) |
34.48 - 87.19 | 265,780 | 180,000 | 0 | ||
| 17-05-2021 | PM | 7:00 AM ET (May 17) |
ZNTL | Zentalis Pharmaceuticals, Inc. | 2,379 | -1.24 | -0.96 | 0.00 | Zentalis Pharmaceuticals EPS misses by $0.27 [5/17/2021 7:54 AM] |
54.53 | -4.29 (-7.29%) |
58.82 | 0.0 (0.00%) |
25.41 - 62.79 | 157,090 | 340,000 | 13,775 | |
| 25-03-2021 | PM | 7:00 AM ET (Mar 25) |
ZNTL | Zentalis Pharmaceuticals, Inc. | 1,725 | -1.01 | -0.97 | 0.00 | Zentalis Pharmaceuticals EPS misses by $0.06 [3/25/2021 7:07 AM] |
40.13 | -0.46 (-1.13%) |
0.0 | 0.0 (0.00%) |
22.00 - 61.29 | 186,764 | 320,000 | 0 | |